line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,107970000.0,PANACEABIO.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.3,PANACEABIO.NS
Normalized EBITDA,2025-03-31 00:00:00,-52500000.0,PANACEABIO.NS
Total Unusual Items,2025-03-31 00:00:00,359900000.0,PANACEABIO.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,359900000.0,PANACEABIO.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,-83700000.0,PANACEABIO.NS
Reconciled Depreciation,2025-03-31 00:00:00,348100000.0,PANACEABIO.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,1995400000.0,PANACEABIO.NS
EBITDA,2025-03-31 00:00:00,307400000.0,PANACEABIO.NS
EBIT,2025-03-31 00:00:00,-40700000.0,PANACEABIO.NS
Net Interest Income,2025-03-31 00:00:00,-38800000.0,PANACEABIO.NS
Interest Expense,2025-03-31 00:00:00,38800000.0,PANACEABIO.NS
Interest Income,2025-03-31 00:00:00,,PANACEABIO.NS
Normalized Income,2025-03-31 00:00:00,-335630000.0,PANACEABIO.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,-83700000.0,PANACEABIO.NS
Total Expenses,2025-03-31 00:00:00,6198100000.0,PANACEABIO.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,PANACEABIO.NS
Diluted Average Shares,2025-03-31 00:00:00,61094891.0,PANACEABIO.NS
Basic Average Shares,2025-03-31 00:00:00,61094891.0,PANACEABIO.NS
Diluted EPS,2025-03-31 00:00:00,-1.37,PANACEABIO.NS
Basic EPS,2025-03-31 00:00:00,-1.37,PANACEABIO.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,-83700000.0,PANACEABIO.NS
Net Income Common Stockholders,2025-03-31 00:00:00,-83700000.0,PANACEABIO.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,PANACEABIO.NS
Net Income,2025-03-31 00:00:00,-83700000.0,PANACEABIO.NS
Minority Interests,2025-03-31 00:00:00,3500000.0,PANACEABIO.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,-87200000.0,PANACEABIO.NS
Net Income Discontinuous Operations,2025-03-31 00:00:00,,PANACEABIO.NS
Net Income Continuous Operations,2025-03-31 00:00:00,-87200000.0,PANACEABIO.NS
Tax Provision,2025-03-31 00:00:00,7700000.0,PANACEABIO.NS
Pretax Income,2025-03-31 00:00:00,-79500000.0,PANACEABIO.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,206600000.0,PANACEABIO.NS
Special Income Charges,2025-03-31 00:00:00,359900000.0,PANACEABIO.NS
Other Special Charges,2025-03-31 00:00:00,-359900000.0,PANACEABIO.NS
Write Off,2025-03-31 00:00:00,,PANACEABIO.NS
Impairment Of Capital Assets,2025-03-31 00:00:00,,PANACEABIO.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-38800000.0,PANACEABIO.NS
Total Other Finance Cost,2025-03-31 00:00:00,,PANACEABIO.NS
Interest Expense Non Operating,2025-03-31 00:00:00,38800000.0,PANACEABIO.NS
Interest Income Non Operating,2025-03-31 00:00:00,,PANACEABIO.NS
Operating Income,2025-03-31 00:00:00,-607200000.0,PANACEABIO.NS
Operating Expense,2025-03-31 00:00:00,4202700000.0,PANACEABIO.NS
Other Operating Expenses,2025-03-31 00:00:00,2124100000.0,PANACEABIO.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,348100000.0,PANACEABIO.NS
Amortization,2025-03-31 00:00:00,,PANACEABIO.NS
Depreciation Income Statement,2025-03-31 00:00:00,348100000.0,PANACEABIO.NS
Selling General And Administration,2025-03-31 00:00:00,,PANACEABIO.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,PANACEABIO.NS
General And Administrative Expense,2025-03-31 00:00:00,,PANACEABIO.NS
Rent And Landing Fees,2025-03-31 00:00:00,,PANACEABIO.NS
Gross Profit,2025-03-31 00:00:00,3595500000.0,PANACEABIO.NS
Cost Of Revenue,2025-03-31 00:00:00,1995400000.0,PANACEABIO.NS
Total Revenue,2025-03-31 00:00:00,5590900000.0,PANACEABIO.NS
Operating Revenue,2025-03-31 00:00:00,5590900000.0,PANACEABIO.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,108090000.0,PANACEABIO.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.3,PANACEABIO.NS
Normalized EBITDA,2024-03-31 00:00:00,57400000.0,PANACEABIO.NS
Total Unusual Items,2024-03-31 00:00:00,360300000.0,PANACEABIO.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,360300000.0,PANACEABIO.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,-11700000.0,PANACEABIO.NS
Reconciled Depreciation,2024-03-31 00:00:00,367100000.0,PANACEABIO.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,2301200000.0,PANACEABIO.NS
EBITDA,2024-03-31 00:00:00,417700000.0,PANACEABIO.NS
EBIT,2024-03-31 00:00:00,50600000.0,PANACEABIO.NS
Net Interest Income,2024-03-31 00:00:00,-35800000.0,PANACEABIO.NS
Interest Expense,2024-03-31 00:00:00,35800000.0,PANACEABIO.NS
Interest Income,2024-03-31 00:00:00,83730000.0,PANACEABIO.NS
Normalized Income,2024-03-31 00:00:00,-263910000.0,PANACEABIO.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,-11700000.0,PANACEABIO.NS
Total Expenses,2024-03-31 00:00:00,6159400000.0,PANACEABIO.NS
Rent Expense Supplemental,2024-03-31 00:00:00,33960000.0,PANACEABIO.NS
Diluted Average Shares,2024-03-31 00:00:00,61578947.0,PANACEABIO.NS
Basic Average Shares,2024-03-31 00:00:00,61578947.0,PANACEABIO.NS
Diluted EPS,2024-03-31 00:00:00,-0.19,PANACEABIO.NS
Basic EPS,2024-03-31 00:00:00,-0.19,PANACEABIO.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,-11700000.0,PANACEABIO.NS
Net Income Common Stockholders,2024-03-31 00:00:00,-11700000.0,PANACEABIO.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,PANACEABIO.NS
Net Income,2024-03-31 00:00:00,-11700000.0,PANACEABIO.NS
Minority Interests,2024-03-31 00:00:00,3300000.0,PANACEABIO.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,-15000000.0,PANACEABIO.NS
Net Income Discontinuous Operations,2024-03-31 00:00:00,,PANACEABIO.NS
Net Income Continuous Operations,2024-03-31 00:00:00,-15000000.0,PANACEABIO.NS
Tax Provision,2024-03-31 00:00:00,29800000.0,PANACEABIO.NS
Pretax Income,2024-03-31 00:00:00,14800000.0,PANACEABIO.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,258000000.0,PANACEABIO.NS
Special Income Charges,2024-03-31 00:00:00,360300000.0,PANACEABIO.NS
Other Special Charges,2024-03-31 00:00:00,-360300000.0,PANACEABIO.NS
Write Off,2024-03-31 00:00:00,5430000.0,PANACEABIO.NS
Impairment Of Capital Assets,2024-03-31 00:00:00,46140000.0,PANACEABIO.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-35800000.0,PANACEABIO.NS
Total Other Finance Cost,2024-03-31 00:00:00,9080000.0,PANACEABIO.NS
Interest Expense Non Operating,2024-03-31 00:00:00,35800000.0,PANACEABIO.NS
Interest Income Non Operating,2024-03-31 00:00:00,83730000.0,PANACEABIO.NS
Operating Income,2024-03-31 00:00:00,-567700000.0,PANACEABIO.NS
Operating Expense,2024-03-31 00:00:00,3858200000.0,PANACEABIO.NS
Other Operating Expenses,2024-03-31 00:00:00,1995400000.0,PANACEABIO.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,367100000.0,PANACEABIO.NS
Amortization,2024-03-31 00:00:00,23510000.0,PANACEABIO.NS
Depreciation Income Statement,2024-03-31 00:00:00,367100000.0,PANACEABIO.NS
Selling General And Administration,2024-03-31 00:00:00,580500000.0,PANACEABIO.NS
Selling And Marketing Expense,2024-03-31 00:00:00,285240000.0,PANACEABIO.NS
General And Administrative Expense,2024-03-31 00:00:00,295260000.0,PANACEABIO.NS
Rent And Landing Fees,2024-03-31 00:00:00,33960000.0,PANACEABIO.NS
Gross Profit,2024-03-31 00:00:00,3290500000.0,PANACEABIO.NS
Cost Of Revenue,2024-03-31 00:00:00,2301200000.0,PANACEABIO.NS
Total Revenue,2024-03-31 00:00:00,5591700000.0,PANACEABIO.NS
Operating Revenue,2024-03-31 00:00:00,5591700000.0,PANACEABIO.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,316242000.0,PANACEABIO.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.3,PANACEABIO.NS
Normalized EBITDA,2023-03-31 00:00:00,-496830000.0,PANACEABIO.NS
Total Unusual Items,2023-03-31 00:00:00,1054140000.0,PANACEABIO.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,1054140000.0,PANACEABIO.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,-332370000.0,PANACEABIO.NS
Reconciled Depreciation,2023-03-31 00:00:00,391230000.0,PANACEABIO.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,2787580000.0,PANACEABIO.NS
EBITDA,2023-03-31 00:00:00,557310000.0,PANACEABIO.NS
EBIT,2023-03-31 00:00:00,166080000.0,PANACEABIO.NS
Net Interest Income,2023-03-31 00:00:00,71240000.0,PANACEABIO.NS
Interest Expense,2023-03-31 00:00:00,38030000.0,PANACEABIO.NS
Interest Income,2023-03-31 00:00:00,115610000.0,PANACEABIO.NS
Normalized Income,2023-03-31 00:00:00,-1070268000.0,PANACEABIO.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,-332370000.0,PANACEABIO.NS
Total Expenses,2023-03-31 00:00:00,5625730000.0,PANACEABIO.NS
Rent Expense Supplemental,2023-03-31 00:00:00,34420000.0,PANACEABIO.NS
Diluted Average Shares,2023-03-31 00:00:00,61250746.0,PANACEABIO.NS
Basic Average Shares,2023-03-31 00:00:00,61250746.0,PANACEABIO.NS
Diluted EPS,2023-03-31 00:00:00,-5.43,PANACEABIO.NS
Basic EPS,2023-03-31 00:00:00,-5.43,PANACEABIO.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,-332370000.0,PANACEABIO.NS
Net Income Common Stockholders,2023-03-31 00:00:00,-332370000.0,PANACEABIO.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,PANACEABIO.NS
Net Income,2023-03-31 00:00:00,-332370000.0,PANACEABIO.NS
Minority Interests,2023-03-31 00:00:00,5080000.0,PANACEABIO.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,-337450000.0,PANACEABIO.NS
Net Income Discontinuous Operations,2023-03-31 00:00:00,,PANACEABIO.NS
Net Income Continuous Operations,2023-03-31 00:00:00,-337450000.0,PANACEABIO.NS
Tax Provision,2023-03-31 00:00:00,465500000.0,PANACEABIO.NS
Pretax Income,2023-03-31 00:00:00,128050000.0,PANACEABIO.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,33430000.0,PANACEABIO.NS
Special Income Charges,2023-03-31 00:00:00,1039670000.0,PANACEABIO.NS
Other Special Charges,2023-03-31 00:00:00,-1073890000.0,PANACEABIO.NS
Write Off,2023-03-31 00:00:00,4280000.0,PANACEABIO.NS
Impairment Of Capital Assets,2023-03-31 00:00:00,29940000.0,PANACEABIO.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,71240000.0,PANACEABIO.NS
Total Other Finance Cost,2023-03-31 00:00:00,6340000.0,PANACEABIO.NS
Interest Expense Non Operating,2023-03-31 00:00:00,38030000.0,PANACEABIO.NS
Interest Income Non Operating,2023-03-31 00:00:00,115610000.0,PANACEABIO.NS
Operating Income,2023-03-31 00:00:00,-1056540000.0,PANACEABIO.NS
Operating Expense,2023-03-31 00:00:00,2838150000.0,PANACEABIO.NS
Other Operating Expenses,2023-03-31 00:00:00,584280000.0,PANACEABIO.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,391230000.0,PANACEABIO.NS
Amortization,2023-03-31 00:00:00,2750000.0,PANACEABIO.NS
Depreciation Income Statement,2023-03-31 00:00:00,388480000.0,PANACEABIO.NS
Selling General And Administration,2023-03-31 00:00:00,585450000.0,PANACEABIO.NS
Selling And Marketing Expense,2023-03-31 00:00:00,427050000.0,PANACEABIO.NS
General And Administrative Expense,2023-03-31 00:00:00,158400000.0,PANACEABIO.NS
Rent And Landing Fees,2023-03-31 00:00:00,34420000.0,PANACEABIO.NS
Gross Profit,2023-03-31 00:00:00,1781610000.0,PANACEABIO.NS
Cost Of Revenue,2023-03-31 00:00:00,2787580000.0,PANACEABIO.NS
Total Revenue,2023-03-31 00:00:00,4569190000.0,PANACEABIO.NS
Operating Revenue,2023-03-31 00:00:00,4569190000.0,PANACEABIO.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,4286924061.845399,PANACEABIO.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.255991,PANACEABIO.NS
Normalized EBITDA,2022-03-31 00:00:00,-16690000.0,PANACEABIO.NS
Total Unusual Items,2022-03-31 00:00:00,16746390000.0,PANACEABIO.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,16746390000.0,PANACEABIO.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,10783150000.0,PANACEABIO.NS
Reconciled Depreciation,2022-03-31 00:00:00,437770000.0,PANACEABIO.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,3176680000.0,PANACEABIO.NS
EBITDA,2022-03-31 00:00:00,16729700000.0,PANACEABIO.NS
EBIT,2022-03-31 00:00:00,16291930000.0,PANACEABIO.NS
Net Interest Income,2022-03-31 00:00:00,-1774450000.0,PANACEABIO.NS
Interest Expense,2022-03-31 00:00:00,1798370000.0,PANACEABIO.NS
Interest Income,2022-03-31 00:00:00,33940000.0,PANACEABIO.NS
Normalized Income,2022-03-31 00:00:00,-1676315938.154601,PANACEABIO.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,10783150000.0,PANACEABIO.NS
Total Expenses,2022-03-31 00:00:00,7110380000.0,PANACEABIO.NS
Rent Expense Supplemental,2022-03-31 00:00:00,33970000.0,PANACEABIO.NS
Diluted Average Shares,2022-03-31 00:00:00,61250746.0,PANACEABIO.NS
Basic Average Shares,2022-03-31 00:00:00,61250746.0,PANACEABIO.NS
Diluted EPS,2022-03-31 00:00:00,176.05,PANACEABIO.NS
Basic EPS,2022-03-31 00:00:00,176.05,PANACEABIO.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,10783150000.0,PANACEABIO.NS
Net Income Common Stockholders,2022-03-31 00:00:00,10783150000.0,PANACEABIO.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,PANACEABIO.NS
Net Income,2022-03-31 00:00:00,10783150000.0,PANACEABIO.NS
Minority Interests,2022-03-31 00:00:00,-190000.0,PANACEABIO.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,10783340000.0,PANACEABIO.NS
Net Income Discontinuous Operations,2022-03-31 00:00:00,0.0,PANACEABIO.NS
Net Income Continuous Operations,2022-03-31 00:00:00,10783340000.0,PANACEABIO.NS
Tax Provision,2022-03-31 00:00:00,3710220000.0,PANACEABIO.NS
Pretax Income,2022-03-31 00:00:00,14493560000.0,PANACEABIO.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,33970000.0,PANACEABIO.NS
Special Income Charges,2022-03-31 00:00:00,16746380000.0,PANACEABIO.NS
Other Special Charges,2022-03-31 00:00:00,-16762130000.0,PANACEABIO.NS
Write Off,2022-03-31 00:00:00,0.0,PANACEABIO.NS
Impairment Of Capital Assets,2022-03-31 00:00:00,15750000.0,PANACEABIO.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-1774450000.0,PANACEABIO.NS
Total Other Finance Cost,2022-03-31 00:00:00,10020000.0,PANACEABIO.NS
Interest Expense Non Operating,2022-03-31 00:00:00,1798370000.0,PANACEABIO.NS
Interest Income Non Operating,2022-03-31 00:00:00,33940000.0,PANACEABIO.NS
Operating Income,2022-03-31 00:00:00,-518150000.0,PANACEABIO.NS
Operating Expense,2022-03-31 00:00:00,3933700000.0,PANACEABIO.NS
Other Operating Expenses,2022-03-31 00:00:00,879790000.0,PANACEABIO.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,437770000.0,PANACEABIO.NS
Amortization,2022-03-31 00:00:00,7600000.0,PANACEABIO.NS
Depreciation Income Statement,2022-03-31 00:00:00,430170000.0,PANACEABIO.NS
Selling General And Administration,2022-03-31 00:00:00,757550000.0,PANACEABIO.NS
Selling And Marketing Expense,2022-03-31 00:00:00,480840000.0,PANACEABIO.NS
General And Administrative Expense,2022-03-31 00:00:00,276710000.0,PANACEABIO.NS
Rent And Landing Fees,2022-03-31 00:00:00,33970000.0,PANACEABIO.NS
Gross Profit,2022-03-31 00:00:00,3415550000.0,PANACEABIO.NS
Cost Of Revenue,2022-03-31 00:00:00,3176680000.0,PANACEABIO.NS
Total Revenue,2022-03-31 00:00:00,6592230000.0,PANACEABIO.NS
Operating Revenue,2022-03-31 00:00:00,6592230000.0,PANACEABIO.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,PANACEABIO.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,PANACEABIO.NS
Normalized EBITDA,2021-03-31 00:00:00,,PANACEABIO.NS
Total Unusual Items,2021-03-31 00:00:00,,PANACEABIO.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,PANACEABIO.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,PANACEABIO.NS
Reconciled Depreciation,2021-03-31 00:00:00,,PANACEABIO.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,PANACEABIO.NS
EBITDA,2021-03-31 00:00:00,,PANACEABIO.NS
EBIT,2021-03-31 00:00:00,,PANACEABIO.NS
Net Interest Income,2021-03-31 00:00:00,,PANACEABIO.NS
Interest Expense,2021-03-31 00:00:00,,PANACEABIO.NS
Interest Income,2021-03-31 00:00:00,32680000.0,PANACEABIO.NS
Normalized Income,2021-03-31 00:00:00,,PANACEABIO.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,PANACEABIO.NS
Total Expenses,2021-03-31 00:00:00,,PANACEABIO.NS
Rent Expense Supplemental,2021-03-31 00:00:00,28670000.0,PANACEABIO.NS
Diluted Average Shares,2021-03-31 00:00:00,,PANACEABIO.NS
Basic Average Shares,2021-03-31 00:00:00,,PANACEABIO.NS
Diluted EPS,2021-03-31 00:00:00,,PANACEABIO.NS
Basic EPS,2021-03-31 00:00:00,,PANACEABIO.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,PANACEABIO.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,PANACEABIO.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,PANACEABIO.NS
Net Income,2021-03-31 00:00:00,,PANACEABIO.NS
Minority Interests,2021-03-31 00:00:00,,PANACEABIO.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,PANACEABIO.NS
Net Income Discontinuous Operations,2021-03-31 00:00:00,-14550000.0,PANACEABIO.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,PANACEABIO.NS
Tax Provision,2021-03-31 00:00:00,,PANACEABIO.NS
Pretax Income,2021-03-31 00:00:00,,PANACEABIO.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,PANACEABIO.NS
Special Income Charges,2021-03-31 00:00:00,,PANACEABIO.NS
Other Special Charges,2021-03-31 00:00:00,,PANACEABIO.NS
Write Off,2021-03-31 00:00:00,0.0,PANACEABIO.NS
Impairment Of Capital Assets,2021-03-31 00:00:00,2660000.0,PANACEABIO.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,PANACEABIO.NS
Total Other Finance Cost,2021-03-31 00:00:00,6450000.0,PANACEABIO.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,PANACEABIO.NS
Interest Income Non Operating,2021-03-31 00:00:00,32680000.0,PANACEABIO.NS
Operating Income,2021-03-31 00:00:00,,PANACEABIO.NS
Operating Expense,2021-03-31 00:00:00,,PANACEABIO.NS
Other Operating Expenses,2021-03-31 00:00:00,,PANACEABIO.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,PANACEABIO.NS
Amortization,2021-03-31 00:00:00,8280000.0,PANACEABIO.NS
Depreciation Income Statement,2021-03-31 00:00:00,,PANACEABIO.NS
Selling General And Administration,2021-03-31 00:00:00,786480000.0,PANACEABIO.NS
Selling And Marketing Expense,2021-03-31 00:00:00,511810000.0,PANACEABIO.NS
General And Administrative Expense,2021-03-31 00:00:00,274670000.0,PANACEABIO.NS
Rent And Landing Fees,2021-03-31 00:00:00,28670000.0,PANACEABIO.NS
Gross Profit,2021-03-31 00:00:00,,PANACEABIO.NS
Cost Of Revenue,2021-03-31 00:00:00,,PANACEABIO.NS
Total Revenue,2021-03-31 00:00:00,,PANACEABIO.NS
Operating Revenue,2021-03-31 00:00:00,,PANACEABIO.NS
